Mirataz for Cats - 20mg/g - 3g Tube
962673
Mirataz for Cats – Appetite Stimulant for Managing Weight Loss
Mirataz (mirtazapine transdermal ointment) is a prescription medication formulated to manage weight loss in cats suffering from various underlying health conditions. It is the first and only FDA-approved transdermal medication designed specifically for feline weight management. By stimulating appetite and increasing food intake, Mirataz helps cats regain and maintain their body weight without the need for oral administration.
Feline weight loss can be a symptom of serious medical conditions, including hyperthyroidism, chronic kidney disease, inflammatory bowel disease (IBD), neoplasia, pancreatitis, and liver failure. Cats experiencing these conditions often suffer from reduced appetite, which leads to malnutrition, muscle wasting, and further health complications. Mirataz provides an effective and well-tolerated solution for encouraging weight gain in affected cats.
How Mirataz Works
Mirataz contains the active ingredient mirtazapine, an antidepressant with appetite-stimulating properties. In cats, mirtazapine acts as a serotonin and histamine receptor antagonist, which helps to increase appetite, reduce nausea, and improve food consumption.
Unlike traditional oral medications, Mirataz is formulated as a transdermal ointment. It is applied directly to the inner pinna (ear flap) of the cat’s ear, allowing the medication to be absorbed through the skin. This method of administration eliminates the stress associated with giving pills or liquids, making it easier for both cats and their owners to manage treatment.
VETERINARY PRESCRIPTION REQUIRED
Product Features
- Pack Size: - 3g Tube
- Target Animal: - Cat (Feline)
- Related Condition: - Weight loss in Cats
- Pet Prescription Required?: - Yes
- Active Ingredient: - mirtazapine
- Product Name: - Mirataz for Cats - 5g Tube
More Information
Description
Mirataz for Cats - 20mg/g - 3g Tube
Benefits of Mirataz for Cats
Stimulates Appetite and Weight Gain
Mirataz is clinically proven to increase appetite and promote weight gain in cats experiencing unintentional weight loss. By encouraging food intake, it helps to stabilise body weight and prevent further decline in cats suffering from chronic illnesses.
Non-Oral Administration
Many cats are resistant to taking pills or liquid medications, making oral treatment challenging. Mirataz is applied as a transdermal ointment, reducing stress for both cats and owners. This method ensures proper dosing without the need for forceful administration.
Effective in Managing Weight Loss from Underlying Conditions
Feline weight loss is often linked to chronic illnesses. Mirataz is beneficial in managing weight loss caused by:
- Hyperthyroidism – Overactive thyroid glands increase metabolism, causing rapid weight loss despite normal or increased food intake. Mirataz encourages appetite and helps counteract weight loss.
- Chronic Kidney Disease (CKD) – Cats with CKD frequently experience reduced appetite due to nausea and metabolic imbalances. Mirataz helps improve appetite and food consumption.
- Inflammatory Bowel Disease (IBD) – Digestive tract inflammation leads to nutrient malabsorption and weight loss. Mirataz supports food intake, promoting better digestion and weight maintenance.
- Neoplasia (Cancer) – Cancer can suppress appetite, leading to significant weight loss and muscle wasting. Mirataz helps maintain weight by encouraging consistent food intake.
- Pancreatitis – Inflammation of the pancreas can cause nausea and decreased appetite. Mirataz works to counteract appetite suppression, improving overall nutrition.
- Liver Disease – Liver dysfunction affects metabolism and appetite regulation. Mirataz assists in increasing food consumption, helping to support liver function and prevent malnutrition.
How to Use Mirataz
Mirataz is applied once daily to the inner surface of the cat’s ear. The recommended dosage is a 1.5-inch strip of ointment (equivalent to 2 mg of mirtazapine), which should be spread evenly over the skin. Gloves should be worn during application to avoid accidental human absorption.
The ear should not be cleaned for at least six hours after application to ensure proper absorption. If contact with the medication occurs, the area should be washed thoroughly with soap and water. Treatment duration should be determined by a veterinarian, depending on the cat’s condition and response to the medication.
Safety and Precautions
Mirataz is generally well tolerated, but some cats may experience mild side effects. The most common adverse reactions include increased vocalisation, behavioural changes such as restlessness or hyperactivity, and occasional gastrointestinal disturbances. These effects are typically temporary and resolve with continued use.
Mirataz should not be used in cats with known hypersensitivity to mirtazapine or in those receiving serotonergic medications, as this may increase the risk of serotonin syndrome. It should be used with caution in cats with liver disease, as mirtazapine is metabolised by the liver.
Owners should monitor their cat’s appetite and weight gain throughout treatment and report any concerning changes to their veterinarian. If an overdose occurs, signs such as rapid heart rate, tremors, or agitation may develop, requiring immediate veterinary attention.
Storage and Handling
Mirataz should be stored at room temperature, away from moisture and direct sunlight. The tube should be tightly closed when not in use, and care should be taken to prevent accidental ingestion or skin exposure in humans.
